Literature DB >> 25784155

Norovirus genotype diversity in community-based sporadic gastroenteritis incidents: a five-year study.

Leesa D Bruggink1, Natalie L Dunbar, John A Marshall.   

Abstract

Although norovirus is a known cause of sporadic gastroenteritis, the incidence and genotypes of norovirus associated with sporadic community-based gastroenteritis are poorly understood. The current study examined this issue by using material from alleged food poisoning incidents in the state of Victoria, Australia, for the period 2008-2012. Norovirus was identified, by either ORF (open reading frame) 1 or ORF 2 RT-PCR methodology, in 159 of 379 (42.0%) sporadic gastroenteritis incidents, thereby showing that norovirus was an important cause of sporadic gastroenteritis. The number of sporadic norovirus incidents did not vary significantly from year to year, indicating that the pool of circulating norovirus remained constant. Norovirus ORF 1 genotypes identified included GI.1, GI.2, GI.3, GI.4, GI.b, GI.d, GII.2, GII.4 (including variants 2006a, 2006b, 2007, and 2009), GII.16, GII.22, GII.b, GII.e, and GII.g. Norovirus ORF 2 genotypes identified included GI.1, GI.2, GI.3, GI.4, GI.6, GII.2, GII.3, GII.4 (variants 2006b, 2009, 2009-like, 2012, and "unknown"), GII.6, GII.7, GII.9, GII.12, and GII.13. Five ORF 1/ORF 2 norovirus recombinant forms were confirmed: GII.b/GII.3, GII.e/GII.4 (2012), GII.e/GII.4 (unknown), GII.g/GII.12 and GII.16/GII.2. Although the incidence of ORF 2 GI.3 was significantly higher in children than in adults, this was not the case for other major ORF 2 genotypes (GII.2, GII.4, and GII.6) which occurred equally in all age groups. The findings demonstrate the importance and diverse nature of norovirus in sporadic community-based gastroenteritis incidents and indicate that the development of successful vaccine strategies may be difficult.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ORF 1 genotypes; ORF 2 genotypes; recombinants; vaccination

Mesh:

Substances:

Year:  2015        PMID: 25784155     DOI: 10.1002/jmv.24154

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

Review 1.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

2.  Pediatric norovirus GII.4 infections in Nicaragua, 1999-2015.

Authors:  Filemón Bucardo; Yaoska Reyes; Sylvia Becker-Dreps; Natalie Bowman; Joann F Gruber; Jan Vinjé; Felix Espinoza; Margarita Paniagua; Angel Balmaseda; Lennart Svensson; Johan Nordgren
Journal:  Infect Genet Evol       Date:  2017-10-02       Impact factor: 3.342

3.  An outbreak of norovirus GI-6 infection following a wedding in North West England.

Authors:  K C Smith; T Inns; V Decraene; A Fox; D J Allen; A Shah
Journal:  Epidemiol Infect       Date:  2017-01-30       Impact factor: 4.434

4.  Genotype analysis of noroviruses associated with gastroenteritis outbreaks in childcare centres, Victoria, Australia, 2012-2015.

Authors:  L D Bruggink; J M Moselen; J A Marshall
Journal:  Epidemiol Infect       Date:  2017-04-11       Impact factor: 4.434

5.  Profiling of humoral immune responses to norovirus in children across Europe.

Authors:  Nele Villabruna; Ray W Izquierdo-Lara; Claudia M E Schapendonk; Erwin de Bruin; Felicity Chandler; Tran Thi Nhu Thao; Brenda M Westerhuis; Janko van Beek; Louise Sigfrid; Carlo Giaquinto; Herman Goossens; Julia A Bielicki; Malte Kohns Vasconcelos; Pieter L A Fraaij; Marion P G Koopmans; Miranda de Graaf
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

6.  A norovirus intervariant GII.4 recombinant in Victoria, Australia, June 2016: the next epidemic variant?

Authors:  Leesa Bruggink; Michael Catton; John Marshall
Journal:  Euro Surveill       Date:  2016-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.